Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

Recent findings have shown that aspirin, taken for several years, reduces the long-term risk of some cancers, particularly colorectal cancer. The result that aspirin benefit is detectable at daily low-doses (at least 75mg), the same used for the prevention of cardiovascular disease, positions the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dovizio, Melania, Tacconelli, Stefania, Sostres, Carlos, Ricciotti, Emanuela, Patrignani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816673/
https://www.ncbi.nlm.nih.gov/pubmed/24281340
http://dx.doi.org/10.3390/ph5121346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816673/
https://www.ncbi.nlm.nih.gov/pubmed/24281340
http://dx.doi.org/10.3390/ph5121346

Ejemplares similares